Radiologic tumor border can further stratify prognosis in patients with pancreatic neuroendocrine tumor
15 May 2024, 2 p.m.
Publication date: Available online 15 May 2024Source: PancreatologyAuthor(s): Bokyung Ahn, ...
31st Oct 2019
Despite advances in cancer survival, more than 90 percent of people with pancreatic cancer die within five years. Most patients with pancreatic tumors (and half of those with colorectal cancers) carry a mutation in the KRAS gene, which normally controls cell growth and death.